Analyst Ratings for Akero Therapeutics (AKRO) [Buys]
AKRO Rating Summary
AKRO Price Target Summary
- Highest: $62.00 (JPMorgan)
- Lowest: $30.00 (BofA Securities)
- Average: $49.13
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$49.13 (+142.5%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
Avg. $ Target:
$49.13 (+142.5%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/19/2023 | Cantor Fitzgerald » Updated 3/4/2024 |
Prakhar Agrawal | New Coverage | Overweight (N/A) |
61.00 (41.00) |
52.25 (20.26) |
-61.22% | Details |
| 8/28/2023 | UBS » Updated 3/4/2024 |
Eliana Merle | New Coverage | Buy (N/A) |
42.00 (39.00) |
47.97 (20.26) |
-57.77% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
